ArticleGenes & nutrition2025
The comparison of antioxidant and anti-inflammatory potency of native probiotics and paraprobiotics in DSS-induced colitis mice with a normal diet.
Article in Genes & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut-kidney axis.Animal models and experimental medicine · 2026Article
- Postbiotics: a promising tool in personalized medicine approach for the inflammatory disorders.Molecular and cellular biochemistry · 2026Review
- Preventive Effects of Probiotic and PostbioticJournal of microbiology and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Maintaining a regular and nutritious diet has recently become a significant concern due to its impact on various health conditions. Despite following a normal diet, the presence of inflammation and oxidative stress can have negative consequences, especially in IBD (Inflammatory Bowel Disease) patients. The use of beneficial agents such as probiotics in their inactive form, known as paraprobiotics, can help counteract these adverse effects by exerting antioxidant and anti-inflammatory properties. This study aimed to evaluate and compare the antioxidant and anti-inflammatory properties of native probiotic strains and their inactive derivatives, known as paraprobiotics, in mitigating the harmful effects of DSS-induced colitis. Twenty male wild-type C57BL/6 mice were treated with native probiotic strains, including Lactobacillus reuteri RP100, Lactobacillus plantarum RP42, Lactobacillus plantarum RP119, Lactobacillus plantarum RP155, Bifidobacterium bifidum RP1001, and Bifidobacterium longum RP1044, as well as the derived paraprobiotics. The mice were divided into four experimental groups: normal diet (ND) + PBS, ND + DSS (Dextran Sodium Sulfate), ND + DSS + 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.